Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

15.8K
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
15.8K
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

20
Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous...
20
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

659
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659
Inflammatory Response II: Inflammatory Exudate and Tissue Repair01:24

Inflammatory Response II: Inflammatory Exudate and Tissue Repair

8.4K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
8.4K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

764
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
764
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

1.3K
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotype.

EULAR rheumatology open·2026
Same author

Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?

Clinical rheumatology·2026
Same author

Late-onset psoriatic arthritis: A separate entity.

Joint bone spine·2026
Same author

Bacterial translocation and intestinal permeability in early axial spondyloarthritis association with 5-year outcomes: insights from the DESIR cohort.

Rheumatology (Oxford, England)·2026
Same author

Clinical Images: A painful bipartite patella.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Dubious benefit of three injections of botulinum toxin in refractory chronic neck pain: Retrospective data on 22 patients with a 9-month follow-up.

Joint bone spine·2026
Same journal

Greater trochanteric bursal distension with intra-bursal rice bodies: an unusual MRI presentation.

Joint bone spine·2026
Same journal

Evaluating the Impact of a Rheumatologist-led Comorbidity Review in Patients with Inflammatory Arthritis.

Joint bone spine·2026
Same journal

What cumulative glucocorticoid dose should trigger sparing strategies in polymyalgia rheumatica?

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update.

Joint bone spine·2026
Same journal

Multimodal imaging evaluation of the entheses in spondyloarthritis.

Joint bone spine·2026
Same journal

Club Rhumatismes et Inflammation guidelines for anti-interleukin-1 therapy: 2026 update. What's new?

Joint bone spine·2026
See all related articles

Related Experiment Video

Updated: May 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K

Endothelial dysfunction in joint disease.

Clément Prati1, Céline Demougeot2, Xavier Guillot3

  • 1Service de Rhumatologie, CHRU de Besançon, Besançon, France; EA 4267 Fonctions et Dysfonctions Épithéliales, Université de Franche-Comté, Franche-Comté, France.

Joint Bone Spine
|February 26, 2014
PubMed
Summary
This summary is machine-generated.

Rheumatoid arthritis (RA) patients face accelerated atherosclerosis and reduced life expectancy due to systemic inflammation. Endothelial dysfunction, a key factor in cardiovascular disease, is implicated in RA complications, with potential therapeutic targets emerging.

Keywords:
Endothelial dysfunctionLupusRheumatoid arthritisSpondyloarthritis

More Related Videos

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.6K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.0K

Related Experiment Videos

Last Updated: May 2, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

15.4K
Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.6K
Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

6.0K

Area of Science:

  • Rheumatology and Cardiovascular Science
  • Investigating the link between inflammatory joint diseases and cardiovascular pathology.

Background:

  • Inflammatory joint diseases, including rheumatoid arthritis (RA), are linked to premature and accelerated atherosclerosis.
  • RA patients experience reduced life expectancy, particularly those with extraarticular manifestations, highlighting RA as an independent cardiovascular risk factor.
  • Complex interactions between cardiovascular risk factors, systemic inflammation, and vascular function contribute to elevated cardiovascular risk in RA.

Purpose of the Study:

  • To explore the role of endothelial dysfunction in the cardiovascular complications associated with inflammatory joint diseases.
  • To understand the mechanisms underlying impaired vascular function in rheumatoid arthritis patients.
  • To evaluate the potential of therapeutic interventions targeting endothelial dysfunction for cardiovascular risk reduction in RA.

Main Methods:

  • Review of existing literature and research on inflammatory joint diseases and cardiovascular outcomes.
  • Analysis of mechanisms linking systemic inflammation to endothelial dysfunction and atherogenesis.
  • Examination of clinical trials investigating drugs that target endothelial dysfunction in RA patients.

Main Results:

  • Endothelial dysfunction is identified as a critical early event in atherogenesis and a contributor to plaque progression.
  • Impaired endothelium-dependent vasodilation is a hallmark of endothelial dysfunction, though underlying mechanisms require further elucidation.
  • Emerging evidence suggests that targeting endothelial dysfunction may offer promising therapeutic benefits for cardiovascular complications in RA.

Conclusions:

  • Endothelial dysfunction plays a significant role in the heightened cardiovascular risk observed in patients with inflammatory joint diseases like RA.
  • Further research into the mechanisms of endothelial dysfunction is crucial for developing effective preventative and therapeutic strategies.
  • Targeting endothelial dysfunction represents a promising avenue for managing cardiovascular complications in RA patients.